COVID-19 Impact on Global Onychomycosis Drugs Market Size, Status and Forecast 2020-2026

July 2020 | 97 pages | ID: C701F8D88A3AEN
QYResearch

Abstracts

This report focuses on the global Onychomycosis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Onychomycosis Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Novartis
• Johnson & Johnson
• Bausch Health
• Bayer
• Galderma
• Moberg Pharma
• Cipla
• Biofrontera
• Leo Pharma
• Dr. Reddy's Laboratories
• Medimetriks Pharmaceuticals

Market segment by Type, the product can be split into

• Oral Drugs
• Topical Drugs

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Onychomycosis Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Onychomycosis Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Onychomycosis Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Onychomycosis Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Onychomycosis Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral Drugs
  1.4.3 Topical Drugs
1.5 Market by Application
  1.5.1 Global Onychomycosis Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Onychomycosis Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Onychomycosis Drugs Industry
    1.6.1.1 Onychomycosis Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Onychomycosis Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Onychomycosis Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Onychomycosis Drugs Market Perspective (2015-2026)
2.2 Onychomycosis Drugs Growth Trends by Regions
  2.2.1 Onychomycosis Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Onychomycosis Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Onychomycosis Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Onychomycosis Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Onychomycosis Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Onychomycosis Drugs Players by Market Size
  3.1.1 Global Top Onychomycosis Drugs Players by Revenue (2015-2020)
  3.1.2 Global Onychomycosis Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Onychomycosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Onychomycosis Drugs Market Concentration Ratio
  3.2.1 Global Onychomycosis Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Onychomycosis Drugs Revenue in 2019
3.3 Onychomycosis Drugs Key Players Head office and Area Served
3.4 Key Players Onychomycosis Drugs Product Solution and Service
3.5 Date of Enter into Onychomycosis Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Onychomycosis Drugs Historic Market Size by Type (2015-2020)
4.2 Global Onychomycosis Drugs Forecasted Market Size by Type (2021-2026)

5 ONYCHOMYCOSIS DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Onychomycosis Drugs Market Size by Application (2015-2020)
5.2 Global Onychomycosis Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Onychomycosis Drugs Market Size (2015-2020)
6.2 Onychomycosis Drugs Key Players in North America (2019-2020)
6.3 North America Onychomycosis Drugs Market Size by Type (2015-2020)
6.4 North America Onychomycosis Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Onychomycosis Drugs Market Size (2015-2020)
7.2 Onychomycosis Drugs Key Players in Europe (2019-2020)
7.3 Europe Onychomycosis Drugs Market Size by Type (2015-2020)
7.4 Europe Onychomycosis Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Onychomycosis Drugs Market Size (2015-2020)
8.2 Onychomycosis Drugs Key Players in China (2019-2020)
8.3 China Onychomycosis Drugs Market Size by Type (2015-2020)
8.4 China Onychomycosis Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Onychomycosis Drugs Market Size (2015-2020)
9.2 Onychomycosis Drugs Key Players in Japan (2019-2020)
9.3 Japan Onychomycosis Drugs Market Size by Type (2015-2020)
9.4 Japan Onychomycosis Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Onychomycosis Drugs Market Size (2015-2020)
10.2 Onychomycosis Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Onychomycosis Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Onychomycosis Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Onychomycosis Drugs Market Size (2015-2020)
11.2 Onychomycosis Drugs Key Players in India (2019-2020)
11.3 India Onychomycosis Drugs Market Size by Type (2015-2020)
11.4 India Onychomycosis Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Onychomycosis Drugs Market Size (2015-2020)
12.2 Onychomycosis Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Onychomycosis Drugs Market Size by Type (2015-2020)
12.4 Central & South America Onychomycosis Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Onychomycosis Drugs Introduction
  13.1.4 Pfizer Revenue in Onychomycosis Drugs Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Novartis
  13.2.1 Novartis Company Details
  13.2.2 Novartis Business Overview and Its Total Revenue
  13.2.3 Novartis Onychomycosis Drugs Introduction
  13.2.4 Novartis Revenue in Onychomycosis Drugs Business (2015-2020)
  13.2.5 Novartis Recent Development
13.3 Johnson & Johnson
  13.3.1 Johnson & Johnson Company Details
  13.3.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.3.3 Johnson & Johnson Onychomycosis Drugs Introduction
  13.3.4 Johnson & Johnson Revenue in Onychomycosis Drugs Business (2015-2020)
  13.3.5 Johnson & Johnson Recent Development
13.4 Bausch Health
  13.4.1 Bausch Health Company Details
  13.4.2 Bausch Health Business Overview and Its Total Revenue
  13.4.3 Bausch Health Onychomycosis Drugs Introduction
  13.4.4 Bausch Health Revenue in Onychomycosis Drugs Business (2015-2020)
  13.4.5 Bausch Health Recent Development
13.5 Bayer
  13.5.1 Bayer Company Details
  13.5.2 Bayer Business Overview and Its Total Revenue
  13.5.3 Bayer Onychomycosis Drugs Introduction
  13.5.4 Bayer Revenue in Onychomycosis Drugs Business (2015-2020)
  13.5.5 Bayer Recent Development
13.6 Galderma
  13.6.1 Galderma Company Details
  13.6.2 Galderma Business Overview and Its Total Revenue
  13.6.3 Galderma Onychomycosis Drugs Introduction
  13.6.4 Galderma Revenue in Onychomycosis Drugs Business (2015-2020)
  13.6.5 Galderma Recent Development
13.7 Moberg Pharma
  13.7.1 Moberg Pharma Company Details
  13.7.2 Moberg Pharma Business Overview and Its Total Revenue
  13.7.3 Moberg Pharma Onychomycosis Drugs Introduction
  13.7.4 Moberg Pharma Revenue in Onychomycosis Drugs Business (2015-2020)
  13.7.5 Moberg Pharma Recent Development
13.8 Cipla
  13.8.1 Cipla Company Details
  13.8.2 Cipla Business Overview and Its Total Revenue
  13.8.3 Cipla Onychomycosis Drugs Introduction
  13.8.4 Cipla Revenue in Onychomycosis Drugs Business (2015-2020)
  13.8.5 Cipla Recent Development
13.9 Biofrontera
  13.9.1 Biofrontera Company Details
  13.9.2 Biofrontera Business Overview and Its Total Revenue
  13.9.3 Biofrontera Onychomycosis Drugs Introduction
  13.9.4 Biofrontera Revenue in Onychomycosis Drugs Business (2015-2020)
  13.9.5 Biofrontera Recent Development
13.10 Leo Pharma
  13.10.1 Leo Pharma Company Details
  13.10.2 Leo Pharma Business Overview and Its Total Revenue
  13.10.3 Leo Pharma Onychomycosis Drugs Introduction
  13.10.4 Leo Pharma Revenue in Onychomycosis Drugs Business (2015-2020)
  13.10.5 Leo Pharma Recent Development
13.11 Dr. Reddy's Laboratories
  10.11.1 Dr. Reddy's Laboratories Company Details
  10.11.2 Dr. Reddy's Laboratories Business Overview and Its Total Revenue
  10.11.3 Dr. Reddy's Laboratories Onychomycosis Drugs Introduction
  10.11.4 Dr. Reddy's Laboratories Revenue in Onychomycosis Drugs Business (2015-2020)
  10.11.5 Dr. Reddy's Laboratories Recent Development
13.12 Medimetriks Pharmaceuticals
  10.12.1 Medimetriks Pharmaceuticals Company Details
  10.12.2 Medimetriks Pharmaceuticals Business Overview and Its Total Revenue
  10.12.3 Medimetriks Pharmaceuticals Onychomycosis Drugs Introduction
  10.12.4 Medimetriks Pharmaceuticals Revenue in Onychomycosis Drugs Business (2015-2020)
  10.12.5 Medimetriks Pharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Onychomycosis Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Onychomycosis Drugs Revenue
Table 3. Ranking of Global Top Onychomycosis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Onychomycosis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral Drugs
Table 6. Key Players of Topical Drugs
Table 7. COVID-19 Impact Global Market: (Four Onychomycosis Drugs Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Onychomycosis Drugs Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Onychomycosis Drugs Players to Combat Covid-19 Impact
Table 12. Global Onychomycosis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Onychomycosis Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Onychomycosis Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Onychomycosis Drugs Market Share by Regions (2015-2020)
Table 16. Global Onychomycosis Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Onychomycosis Drugs Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Onychomycosis Drugs Market Growth Strategy
Table 22. Main Points Interviewed from Key Onychomycosis Drugs Players
Table 23. Global Onychomycosis Drugs Revenue by Players (2015-2020) (Million US$)
Table 24. Global Onychomycosis Drugs Market Share by Players (2015-2020)
Table 25. Global Top Onychomycosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Onychomycosis Drugs as of 2019)
Table 26. Global Onychomycosis Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Onychomycosis Drugs Product Solution and Service
Table 29. Date of Enter into Onychomycosis Drugs Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Onychomycosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 32. Global Onychomycosis Drugs Market Size Share by Type (2015-2020)
Table 33. Global Onychomycosis Drugs Revenue Market Share by Type (2021-2026)
Table 34. Global Onychomycosis Drugs Market Size Share by Application (2015-2020)
Table 35. Global Onychomycosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 36. Global Onychomycosis Drugs Market Size Share by Application (2021-2026)
Table 37. North America Key Players Onychomycosis Drugs Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Onychomycosis Drugs Market Share (2019-2020)
Table 39. North America Onychomycosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 40. North America Onychomycosis Drugs Market Share by Type (2015-2020)
Table 41. North America Onychomycosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. North America Onychomycosis Drugs Market Share by Application (2015-2020)
Table 43. Europe Key Players Onychomycosis Drugs Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Onychomycosis Drugs Market Share (2019-2020)
Table 45. Europe Onychomycosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Onychomycosis Drugs Market Share by Type (2015-2020)
Table 47. Europe Onychomycosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Onychomycosis Drugs Market Share by Application (2015-2020)
Table 49. China Key Players Onychomycosis Drugs Revenue (2019-2020) (Million US$)
Table 50. China Key Players Onychomycosis Drugs Market Share (2019-2020)
Table 51. China Onychomycosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. China Onychomycosis Drugs Market Share by Type (2015-2020)
Table 53. China Onychomycosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. China Onychomycosis Drugs Market Share by Application (2015-2020)
Table 55. Japan Key Players Onychomycosis Drugs Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Onychomycosis Drugs Market Share (2019-2020)
Table 57. Japan Onychomycosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Onychomycosis Drugs Market Share by Type (2015-2020)
Table 59. Japan Onychomycosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Onychomycosis Drugs Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Onychomycosis Drugs Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Onychomycosis Drugs Market Share (2019-2020)
Table 63. Southeast Asia Onychomycosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Onychomycosis Drugs Market Share by Type (2015-2020)
Table 65. Southeast Asia Onychomycosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Onychomycosis Drugs Market Share by Application (2015-2020)
Table 67. India Key Players Onychomycosis Drugs Revenue (2019-2020) (Million US$)
Table 68. India Key Players Onychomycosis Drugs Market Share (2019-2020)
Table 69. India Onychomycosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 70. India Onychomycosis Drugs Market Share by Type (2015-2020)
Table 71. India Onychomycosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 72. India Onychomycosis Drugs Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Onychomycosis Drugs Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Onychomycosis Drugs Market Share (2019-2020)
Table 75. Central & South America Onychomycosis Drugs Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Onychomycosis Drugs Market Share by Type (2015-2020)
Table 77. Central & South America Onychomycosis Drugs Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Onychomycosis Drugs Market Share by Application (2015-2020)
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Onychomycosis Drugs Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Onychomycosis Drugs Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Product
Table 92. Johnson & Johnson Revenue in Onychomycosis Drugs Business (2015-2020) (Million US$)
Table 93. Johnson & Johnson Recent Development
Table 94. Bausch Health Company Details
Table 95. Bausch Health Business Overview
Table 96. Bausch Health Product
Table 97. Bausch Health Revenue in Onychomycosis Drugs Business (2015-2020) (Million US$)
Table 98. Bausch Health Recent Development
Table 99. Bayer Company Details
Table 100. Bayer Business Overview
Table 101. Bayer Product
Table 102. Bayer Revenue in Onychomycosis Drugs Business (2015-2020) (Million US$)
Table 103. Bayer Recent Development
Table 104. Galderma Company Details
Table 105. Galderma Business Overview
Table 106. Galderma Product
Table 107. Galderma Revenue in Onychomycosis Drugs Business (2015-2020) (Million US$)
Table 108. Galderma Recent Development
Table 109. Moberg Pharma Company Details
Table 110. Moberg Pharma Business Overview
Table 111. Moberg Pharma Product
Table 112. Moberg Pharma Revenue in Onychomycosis Drugs Business (2015-2020) (Million US$)
Table 113. Moberg Pharma Recent Development
Table 114. Cipla Business Overview
Table 115. Cipla Product
Table 116. Cipla Company Details
Table 117. Cipla Revenue in Onychomycosis Drugs Business (2015-2020) (Million US$)
Table 118. Cipla Recent Development
Table 119. Biofrontera Company Details
Table 120. Biofrontera Business Overview
Table 121. Biofrontera Product
Table 122. Biofrontera Revenue in Onychomycosis Drugs Business (2015-2020) (Million US$)
Table 123. Biofrontera Recent Development
Table 124. Leo Pharma Company Details
Table 125. Leo Pharma Business Overview
Table 126. Leo Pharma Product
Table 127. Leo Pharma Revenue in Onychomycosis Drugs Business (2015-2020) (Million US$)
Table 128. Leo Pharma Recent Development
Table 129. Dr. Reddy's Laboratories Company Details
Table 130. Dr. Reddy's Laboratories Business Overview
Table 131. Dr. Reddy's Laboratories Product
Table 132. Dr. Reddy's Laboratories Revenue in Onychomycosis Drugs Business (2015-2020) (Million US$)
Table 133. Dr. Reddy's Laboratories Recent Development
Table 134. Medimetriks Pharmaceuticals Company Details
Table 135. Medimetriks Pharmaceuticals Business Overview
Table 136. Medimetriks Pharmaceuticals Product
Table 137. Medimetriks Pharmaceuticals Revenue in Onychomycosis Drugs Business (2015-2020) (Million US$)
Table 138. Medimetriks Pharmaceuticals Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Onychomycosis Drugs Market Share by Type: 2020 VS 2026
Figure 2. Oral Drugs Features
Figure 3. Topical Drugs Features
Figure 4. Global Onychomycosis Drugs Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Onychomycosis Drugs Report Years Considered
Figure 9. Global Onychomycosis Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Onychomycosis Drugs Market Share by Regions: 2020 VS 2026
Figure 11. Global Onychomycosis Drugs Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Onychomycosis Drugs Market Share by Players in 2019
Figure 14. Global Top Onychomycosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Onychomycosis Drugs as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Onychomycosis Drugs Revenue in 2019
Figure 16. North America Onychomycosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Onychomycosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Onychomycosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Onychomycosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Onychomycosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Onychomycosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Onychomycosis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Pfizer Revenue Growth Rate in Onychomycosis Drugs Business (2015-2020)
Figure 25. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Novartis Revenue Growth Rate in Onychomycosis Drugs Business (2015-2020)
Figure 27. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Johnson & Johnson Revenue Growth Rate in Onychomycosis Drugs Business (2015-2020)
Figure 29. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bausch Health Revenue Growth Rate in Onychomycosis Drugs Business (2015-2020)
Figure 31. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Bayer Revenue Growth Rate in Onychomycosis Drugs Business (2015-2020)
Figure 33. Galderma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Galderma Revenue Growth Rate in Onychomycosis Drugs Business (2015-2020)
Figure 35. Moberg Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Moberg Pharma Revenue Growth Rate in Onychomycosis Drugs Business (2015-2020)
Figure 37. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Cipla Revenue Growth Rate in Onychomycosis Drugs Business (2015-2020)
Figure 39. Biofrontera Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Biofrontera Revenue Growth Rate in Onychomycosis Drugs Business (2015-2020)
Figure 41. Leo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Leo Pharma Revenue Growth Rate in Onychomycosis Drugs Business (2015-2020)
Figure 43. Dr. Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Dr. Reddy's Laboratories Revenue Growth Rate in Onychomycosis Drugs Business (2015-2020)
Figure 45. Medimetriks Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Medimetriks Pharmaceuticals Revenue Growth Rate in Onychomycosis Drugs Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed